Adage Capital Partners Gp, L.L.C. Logic Bio Therapeutics, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$5.41 - $9.45 $4.33 Million - $7.56 Million	-800,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.25 - $8.46 $490,258 - $975,903	-115,355 Reduced 12.6%	800,000 $6.77 Million
Q1 2020 May 15, 2020	SELL	$4.06 - $11.0 $1.34 Million - $3.64 Million	-331,199 Reduced 26.57%	915,355 $4.52 Million
Q4 2019 Feb 14, 2020	SELL	$7.01 - $11.01 $924,766 - $1.45 Million	-131,921 Reduced 9.57%	1,246,554 $8.98 Million
Q3 2019 Nov 14, 2019	BUY	$6.97 - $13.46 $546,970 - $1.06 Million	78,475 Added 6.04%	1,378,475 $14.9 Million
Q2 2019 Aug 14, 2019	BUY	$9.77 - $17.08 $3.81 Million - $6.66 Million	390,000 Added 42.86%	1,300,000 $16.9 Million
Q4 2018 Feb 14, 2019	BUY	$7.88 - $17.98 $7.17 Million - $16.4 Million	910,000 New	910,000 $9.46 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.